AMLN Amylin Pharmaceuticals, Inc. (MM)

Amylin Pharmaceuticals to Present at Thomas Weisel Healthcare Conference and BioCentury NewsMakers Conference SAN DIEGO, Sept. 2 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) will be presenting at the Thomas Weisel Partners Healthcare Tailwinds 2004 Conference on Wednesday, September 8, 2004 at 9:10 AM Eastern Time in Boston and at BioCentury's NewsMakers in the Biotech Industry Conference on Thursday, September 9, 2004 at 10:30 a.m. Eastern Time in New York. Mark G. Foletta, Vice President, Finance and Chief Financial Officer of Amylin Pharmaceuticals, will be providing a corporate overview at Thomas Weisel. Ginger L. Graham, President & Chief Executive Officer of Amylin Pharmaceuticals, will be presenting at BioCentury. Both presentations will be webcast live, and recordings will be made available following each presentation. The breakout session at BioCentury will also be webcast live, and a recording will be made available following the session. The webcasts and recordings will be accessible through Amylin's corporate website, located at http://www.amylin.com/. For access, please log on to Amylin's site approximately fifteen minutes prior to the presentations to register and download any necessary audio software. Amylin Pharmaceuticals is committed to improving the lives of people with diabetes and other metabolic diseases through the discovery, development and commercialization of innovative, cost-effective medicines. Further information on Amylin Pharmaceuticals and its pipeline in metabolism is available at http://www.amylin.com/. DATASOURCE: Amylin Pharmaceuticals CONTACT: Mark G. Foletta, Vice President of Finance and Chief Financial Officer of Amylin Pharmaceuticals, Inc., +1-858-552-2200 Web site: http://www.amylin.com/

Copyright